Mikko Niemi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Topics

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Chronic Lymphocytic Leukemia

Top Venues

Clinical pharmacology and therapeutics

Molecular pharmaceutics

Clinical and translational science

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, Aleksi Tornio, Janne T Backman, Marko Lehtonen, Mikko Niemi
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and translational science 17 (3) (2024)
Mika Lehto, Alex Luojus, Olli Halminen, Jari K Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, Ossi Lehtonen, Konsta Teppo, Paula Tiili, Elis Kouki, Saga Itäinen-Strömberg, Mikko Niemi, Aapo L Aro, Juha E K Hartikainen, Kari Eino Juhani Airaksinen, null null
Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study. Annals of medicine 56 (1) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics 115 (6) (2024)
Mika Lehto, Alex Luojus, Olli Halminen, Jari K Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, Ossi Lehtonen, Konsta Teppo, Paula Tiili, Elis Kouki, Saga Itäinen-Strömberg, Mikko Niemi, Aapo L Aro, Juha E K Hartikainen, Kari Eino Juhani Airaksinen, null null
Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study. Annals of medicine 56 (1) (2024)
Kreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, Aleksi Tornio, Janne T Backman, Marko Lehtonen, Mikko Niemi
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and translational science 17 (3) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics 115 (6) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics (2024)
Feng Deng, Kreetta Hämäläinen, Minna Lehtisalo, Mikko Neuvonen, Mikko Niemi
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4. Clinical pharmacology and therapeutics (2024)
Mika Lehto, Alex Luojus, Olli Halminen, Jari K Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, Ossi Lehtonen, Konsta Teppo, Paula Tiili, Elis Kouki, Saga Itäinen-Strömberg, Mikko Niemi, Aapo L Aro, Juha E K Hartikainen, Kari Eino Juhani Airaksinen, null null
Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study. Annals of medicine 56 (1) (2024)
Minna Lehtisalo, Wilma Kiander, Anne M Filppula, Feng Deng, Heidi Kidron, Mari Korhonen, Johanna Sinkko, Kimmo Koivula, Mikko Niemi
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein-mediated drug interaction? British journal of clinical pharmacology (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics 20 (3) (2023)
Christine C Orozco, Mikko Neuvonen, Yi-An Bi, Matthew A Cerny, Sumathy Mathialagan, Laurie Tylaska, Brian Rago, Chester Costales, Amanda King-Ahmad, Mikko Niemi, A David Rodrigues
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides. Molecular pharmaceutics (2023)
Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen, Mikko Holmberg, Johanna I Kiiski, Outi Lapatto-Reiniluoto, Anne M Filppula, Mika Kurkela, Janne T Backman, Mikko Niemi
Ticagrelor increases exposure to the breast cancer resistance protein substrate rosuvastatin. Clinical pharmacology and therapeutics (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics 20 (3) (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics 20 (3) (2023)
Minna Lehtisalo, Wilma Kiander, Anne M Filppula, Feng Deng, Heidi Kidron, Mari Korhonen, Johanna Sinkko, Kimmo Koivula, Mikko Niemi
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin - a breast cancer resistance protein -mediated drug interaction? British journal of clinical pharmacology (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics 20 (3) (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics 20 (3) (2023)
Aleksi M Olkkola, Tuija Tapaninen, Aleksi Tornio, Milka Hauta-Aho, Outi Lapatto-Reiniluoto, Mikko Neuvonen, Johanna I Kiiski, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment. British journal of clinical pharmacology (2023)
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V Ahola-Olli, Mikko Niemi
Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular pharmaceutics (2023)
Jaakko Lähteenmäki, Anna-Leena Vuorinen, Mika Lehto, Mikko Niemi, Markus M Forsberg
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis. Pharmacoepidemiology and drug safety 32 (3) (2022)
Laura B Ramsey, Li Gong, Seung-Been Lee, Jonathan B Wagner, Xujia Zhou, Katrin Sangkuhl, Solomon M Adams, Robert J Straka, Philip E Empey, Erin C Boone, Teri E Klein, Mikko Niemi, Andrea Gaedigk
PharmVar GeneFocus: SLCO1B1. Clinical pharmacology and therapeutics (2022)
Jaakko Lähteenmäki, Anna-Leena Vuorinen, Mika Lehto, Mikko Niemi, Markus M Forsberg
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis. Pharmacoepidemiology and drug safety 32 (3) (2022)
Katja Häkkinen, Johanna I Kiiski, Markku Lähteenvuo, Tuomas Jukuri, Kimmo Suokas, Jussi Niemi-Pynttäri, Tuula Kieseppä, Teemu Männynsalo, Asko Wegelius, Willehard Haaki, Kaisla Lahdensuo, Risto Kajanne, Mari A Kaunisto, Annamari Tuulio-Henriksson, Olli Kampman, Jarmo Hietala, Juha Veijola, Jouko Lönnqvist, Erkki Isometsä, Tiina Paunio, Jaana Suvisaari, Eija A Kalso, Mikko Niemi, Jari Tiihonen, Mark Daly, Aarno Palotie, Ari V Ahola-Olli
Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder. The pharmacogenomics journal 22 (3) (2022)
Anssi J H Mykkänen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, E Katriina Tarkiainen, Tuomas Olavi Lilius, Tuija Tapaninen, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genomewide Association Study of Simvastatin Pharmacokinetics. Clinical pharmacology and therapeutics 112 (3) (2022)
Jaakko Lähteenmäki, Anna-Leena Vuorinen, Mika Lehto, Mikko Niemi, Markus M Forsberg
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis. Pharmacoepidemiology and drug safety 32 (3) (2022)
Jaakko Lähteenmäki, Anna-Leena Vuorinen, Mika Lehto, Mikko Niemi, Markus M Forsberg
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis. Pharmacoepidemiology and drug safety (2022)
Minna Lehtisalo, Suvi Taskinen, E Katriina Tarkiainen, Mikko Neuvonen, Jenni Viinamäki, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Janne T Backman, Aleksi Tornio, Mikko Niemi
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. British journal of clinical pharmacology (2022)
Päivi Hirvensalo, Aleksi Tornio, Tuija Tapaninen, Maria Paile-Hyvärinen, Mikko Neuvonen, Janne T Backman, Mikko Niemi
Pharmacogenomics of celiprolol - evidence for a role of P-glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics. Clinical and translational science (2021)
Anna-Leena Vuorinen, Mika Lehto, Mikko Niemi, Kari Harno, Juha Pajula, Mark van Gils, Jaakko Lähteenmäki
Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland. Clinical epidemiology 13 (2021)
Topi Hovinen, Liisa Korkalo, Riitta I Freese, Essi Skaffari, Pirjo Isohanni, Mikko Niemi, Jaakko Nevalainen, Helena Gylling, Nicola Zamboni, Maijaliisa Erkkola, Anu Suomalainen
Vegan diet in young children remodels metabolism and challenges the statuses of essential nutrients. EMBO molecular medicine 13 (2) (2021)
Päivi Hirvensalo, Aleksi Tornio, Terhi Launiainen, Maria Paile-Hyvärinen, Tuija Tapaninen, Mikko Neuvonen, Janne T Backman, Mikko Niemi
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study. Clinical pharmacology and therapeutics 108 (4) (2020)
Matti K Itkonen, Aleksi Tornio, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans. Drug metabolism and disposition: the biological fate of chemicals 47 (4) (2019)
Tuija Tapaninen, Aleksi M Olkkola, Aleksi Tornio, Mikko Neuvonen, Erkki Elonen, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug Interaction. Clinical and translational science 13 (2) (2019)
Päivi Hirvensalo, Aleksi Tornio, Mikko Neuvonen, Wilma Kiander, Heidi Kidron, Maria Paile-Hyvärinen, Tuija Tapaninen, Janne T Backman, Mikko Niemi
Enantiospecific Pharmacogenomics of Fluvastatin. Clinical pharmacology and therapeutics 106 (3) (2019)
Helinä Kahma, Anne M Filppula, Mikko Neuvonen, E Katriina Tarkiainen, Aleksi Tornio, Mikko T Holmberg, Matti K Itkonen, Moshe Finel, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions . Drug metabolism and disposition: the biological fate of chemicals 46 (2) (2017)